Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 03-August 22, 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Test material form:
- solid: particulate/powder
- Details on test material:
- Batch No.: UGe-RS Kilo 1
Color: Yellow
Odor: Not specific
Storage conditions: room temperature
Solubility and stability: Very good solubility in water, stable in solution at least 2 days
Expiring date: 12.12.2018
Correction factor: 1.07
Constituent 1
- Specific details on test material used for the study:
- Test item: Yellow LF 6911
Batch No.: UGe-RS Kilo 1
Appearance: Yellow powder
Expiration date: 12 December 2018
Storage: Room temperature
Safety precautions: Routine safety precautions (gloves, goggles, face mask, lab coat) were applied to assure personnel health and safety.
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA/Ca
- Sex:
- female
- Details on test animals and environmental conditions:
- Species and strain: CBA/Ca Ola Hsd mice
Source: TOXI-COOP ZRT., H-1103, Budapest, Cserkesz u. 90.
Hygienic level at arrival: SPF
Hygienic level during the test: Good conventional
Number of animals: 28 animals/main test (4 animals/treatment group)
Sex: Female, nulliparous, non-pregnant
Age of animals: Young adult mice; 10 weeks old (at start of the main test)
Body weight range at starting:16.6 – 21.4 g
The weight variation in animals involved in the study did not exceed 20 % of the mean weight.
Acclimatization time: 7 days
Housing during the test: Grouped caging (4 animals/cage)
Cage type: Type II. Polypropylene / polycarbonate
Bedding: Laboratory bedding
Light: 12 hours daily, from 6.00 a.m. to 6.00 p.m.
Temperature: 22 ± 3 °C
Relative humidity: 30 – 70 %
In-life phase: June 15- June 21, 2016
Study design: in vivo (LLNA)
- Vehicle:
- dimethyl sulphoxide
- Concentration:
- 25 %, 10 %, 5 % or 2.5 % (w/v)
- No. of animals per dose:
- 4 animals/treatment group
- Details on study design:
- Based on the preliminary test results the maximum attainable concentration (based on solubility) of 25 % (w/v) was used in the main test. The test item was tested also at three additional, lower concentrations (10 %, 5 % and 2.5 %, w/v) to evaluate dose-response relationship and ensure validity of the test in accordance with the relevant guidelines.
Animals in the treatment groups were treated with the negative (vehicle) controls (DMSO or AOO), appropriate formulations of the test item or 25 % (w/v) concentration of the positive control substance. The test item was administered at four different concentrations according to the results of the dose range finding test.
Table 2. Criteria for Erythema Scores
Observation Score
No erythema 0
Very slight erythema (barely perceptible) 1
Well-defined erythema 2
Moderate to severe erythema 3
Severe erythema (beet redness) to eschar
formation preventing grading of erythema 4
Groups Test item concentration(% w/v) Positive control
concentration (% w/v) No. of animals
1 Vehicle control for the positive control: AOO - - 4
2 Positive control: HCA in AOO - 25 4
3 Vehicle control for the test item: DMSO - - 4
4 Yellow LF 6911 in DMSO 25 - 4
5 Yellow LF 6911 in DMSO 10 - 4
6 Yellow LF 6911 in DMSO 5 - 4
7 Yellow LF 6911 in DMSO 2.5 - 4
In vivo Treatment
Each mouse was topically treated with 25 L of the appropriate formulations of the test item, the positive control substance or the vehicles (see Table 3) using a pipette, on the dorsal surface of each ear. After the treatments animals were returned to their cages. Each animal was dosed once a day for three consecutive days (Days 1, 2 and 3). There was no treatment on Days 4, 5 and 6.
Proliferation Assay
No animals showed symptoms of systemic toxicity or excessive skin irritation, and no technical treatment failures were observed during the test: all animals treated were processed. Therefore no treatment group was excluded from the evaluation.
Injection of 3HTdR
On Day 6 each mouse was intravenously injected via the tail vein with 250 L of sterile PBS (1 x PBS, diluted from 10x concentrate) containing approximately 20 microCi# of
3H-methyl-thymidine using a hypodermic needle with 1 mL sterile syringe. Once injected, mice were left for 5 hours (± 30 minutes).
Removal and Preparation of Draining Auricular Lymph Nodes
Five hours (± 30 minutes) after intravenous injection the mice were sacrificed by cervical dislocation. The draining auricular lymph nodes were excised by making a small incision in the skin between the jaw and the sternum, pulling the skin gently back towards the ears and exposing the lymph nodes. Then the nodes were removed using forceps. Once removed, the nodes of the mice from each test group were pooled and collected separately in a Petri dish containing a small amount (1-2 mL) of PBS to keep the nodes wet before processing.
Preparation of Single Cell Suspension of Lymph Node Cells
A single cell suspension (SCS) of lymph node cells (LNCs), pooled according to groups, was prepared and collected in disposable tubes by gentle mechanical disaggregating of the lymph nodes through a cell strainer using the plunger of a disposable syringe. The cell strainer was washed with PBS (up to 10 mL). LNCs were pelleted with a relative centrifugal force (RCF) of approximately 190 x g for 10 minutes at 4 C. After centrifugation, the supernatant was removed, leaving 1-2 mL supernatant above each pellet. The pellets were gently agitated before making up to 10 mL with PBS and re-suspending the LNCs. The washing procedure was repeated twice. This procedure was repeated for each group of pooled lymph nodes.
Determination of Incorporated 3HTdR
After the final wash, each supernatant was removed leaving a small volume (< 0.5 mL) of supernatant above each pellet. The pellets were gently agitated before suspending the LNCs in 3 mL of 5 % (w/v) trichloroacetic acid (TCA, dissolved in purified water) for precipitation of the macromolecules. After incubation with 5 % TCA at 2-8C overnight (approx. 18 hrs), each precipitate was removed by centrifugation of the samples at approximately 190 x g for 10 minutes at 4C and decanting the supernatants, than the pellets were re-suspended in 1 mL of 5 % TCA and dispersed using an ultrasonic water bath. Samples were transferred to suitable sized scintillation vials containing 10 mL of scintillation liquid, gently mixed and loaded into the -scintillation counter. 3HTdR incorporation was measured for up to 10 minutes per sample. The -counter expressed the 3HTdR incorporation as the amount of radioactive disintegration per minute (DPM). Similarly, background 3HTdR levels were measured in two 1 mL aliquots of 5 % TCA. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Randomization based on body weigt was checked by SPSS PC+
Calculation of stimulation indices were made by EXCEL software
Results and discussion
- Positive control results:
- The positive control group animals were treated with 25 % (w/v) HCA solution (formulated in AOO) concurrent to the test item groups. No mortality, cutaneous reactions or signs of toxicity were observed in the positive control group.
Significant lymphoproliferative response (SI 3) was noted for HCA (SI = 11.9). The results of the positive control item demonstrated appropriate performance of the test in accordance with the relevant guidelines and confirmed validity of the assay.
In vivo (LLNA)
Results
- Key result
- Parameter:
- SI
- Value:
- >= 3
- Variability:
- r = 0.56, p = 0.44
- Test group / Remarks:
- SI values were 1.2, 1.2, 2.6 and 1.6 at 25 %, 10 %, 5 % and 2.5 % (w/v) concentrations
- Cellular proliferation data / Observations:
- No mortality or symptoms of systemic toxicity were observed in any treatment group. No sign of irritation (indicated by an erythema score 3) or any other local effect were observed in any treatment group.
No significant, treatment related effect on body weights was observed during the test. Body weight, decreased by > 5 % was observed in the AOO treatment group only (1/4 animals, 7 % decrease) but it was considered neither significant nor treatment related.
No significant lymphoproliferative response (SI 3) compared to the relevant control (DMSO) was noted for Yellow LF 6911 at the applied test concentrations. The observed stimulation index values were 1.2, 1.2, 2.6 and 1.6 at test item concentrations of 25 %, 10 %, 5 % and 2.5 % (w/v), respectively.
Significance of the dose-response was evaluated by linear regression using the SI values. No statistical significance was observed (p = 0.44, r = 0.56).
Any other information on results incl. tables
Individual Body Weights of the Animals with Group Means, the Associated Error Termsand Body Weight Changes in the Main Test:
Animal |
Dose Group |
Initial |
Terminal |
Body Weight |
Number |
|
Body Weight |
Body Weight |
Change |
|
|
(g) |
(g) |
(%) |
52 |
Vehicle control for the positive control: |
16.6 |
16.5 |
-1 |
53 |
AOO |
19.8 |
18.5 |
-7 |
54 |
|
20.3 |
21.5 |
6 |
55 |
|
18.0 |
20.0 |
11 |
|
Mean |
18.7 |
19.1 |
2 |
|
SD |
1.7 |
2.1 |
|
56 |
Positive control: |
18.3 |
18.8 |
3 |
57 |
25 % HCA |
20.2 |
20.7 |
2 |
58 |
in AOO |
17.7 |
18.2 |
3 |
59 |
|
20.8 |
20.6 |
-1 |
|
Mean |
19.3 |
19.6 |
2 |
|
SD |
1.5 |
1.3 |
|
60 |
Vehicle control for the test item: |
20.0 |
21.4 |
7 |
61 |
DMSO |
21.3 |
20.8 |
-2 |
62 |
|
18.3 |
17.8 |
-3 |
63 |
|
17.8 |
18.3 |
3 |
|
Mean |
19.4 |
19.6 |
1 |
|
SD |
1.6 |
1.8 |
|
64 |
Yellow LF 6911 |
18.1 |
18.8 |
4 |
65 |
25 % |
17.5 |
18.4 |
5 |
66 |
in DMSO |
20.6 |
21.1 |
2 |
67 |
|
20.1 |
20.8 |
3 |
|
Mean |
19.1 |
19.8 |
4 |
|
SD |
1.5 |
1.4 |
|
68 |
Yellow LF 6911 |
18.8 |
18.3 |
-3 |
69 |
10 % |
21.2 |
22.9 |
8 |
70 |
in DMSO |
19.3 |
19.2 |
-1 |
71 |
|
17.3 |
17.7 |
2 |
|
Mean |
19.2 |
19.5 |
2 |
|
SD |
1.6 |
2.3 |
|
72 |
Yellow LF 6911 |
19.5 |
19.9 |
2 |
73 |
5 % |
18.0 |
17.8 |
-1 |
74 |
in DMSO |
20.6 |
20.9 |
1 |
75 |
|
17.5 |
17.2 |
-2 |
|
Mean |
18.9 |
19.0 |
0 |
|
SD |
1.4 |
1.7 |
|
76 |
Yellow LF 6911 |
21.4 |
22.4 |
5 |
77 |
2.5 % |
19.0 |
19.3 |
2 |
78 |
in DMSO |
17.7 |
17.7 |
0 |
79 |
|
18.1 |
19.2 |
6 |
|
Mean |
19.1 |
19.7 |
3 |
|
SD |
1.7 |
2.0 |
|
HCA =a-Hexylcinnamaldehyde
AOO = Acetone: Olive oil 4:1 (v/v) mixture
DMSO = Dimethyl sulfoxide
Individual Ear Thickness Values and the Deviations from the Initial Values in the Dose Range Finding Test:
Dose Group |
Animal |
Ears |
Day 1* |
Day 3$ |
Day 3 |
Day 6# |
Day 6 |
|
Number |
value (mm) |
value (mm) |
% deviation |
value (mm) |
% deviation |
|
|
970 |
L |
0.21 |
0.22 |
4.8 |
0.24 |
14.3 |
Yellow LF 6911 |
|
R |
0.21 |
0.21 |
0.0 |
0.24 |
14.3 |
25 % in DMSO |
984 |
L |
0.21 |
0.21 |
0.0 |
0.23 |
9.5 |
|
|
R |
0.21 |
0.21 |
0.0 |
0.23 |
9.5 |
|
971 |
L |
0.21 |
0.22 |
4.8 |
0.25 |
19.0 |
Yellow LF 6911 |
|
R |
0.21 |
0.22 |
4.8 |
0.24 |
14.3 |
10 % in DMSO |
48 |
L |
0.21 |
0.23 |
9.5 |
0.23 |
9.5 |
|
|
R |
0.21 |
0.23 |
9.5 |
0.23 |
9.5 |
L = Left R = Right
DMSO = Dimethyl sulfoxide
* Ear thickness was measured prior to the first treatment.
$ Ear thickness was measured approximately 48 hours after the first treatment (prior to the third treatment).
# Ear thickness was measured at the end of the test.
DPM and Stimulation Index Values for all Groups in the Main Test:
Dose Group |
Measured |
Group* |
DPM/Mouse# |
Stimulation |
|
DPM/group |
DPM |
|
Index Values |
Vehicle control for the positive control: |
4258 |
4229.5 |
1057.4 |
1.0 |
AOO |
|
|
|
|
Positive control: |
50157 |
50128.5 |
12532.1 |
11.9 |
25 % HCA in AOO |
|
|
|
|
Vehicle control for the test item: |
3607 |
3578.5 |
894.6 |
1.0 |
DMSO |
|
|
|
|
Yellow LF 6911 |
4286 |
4257.5 |
1064.4 |
1.2 |
25 % in DMSO |
|
|
|
|
Yellow LF 6911 |
4265 |
4236.5 |
1059.1 |
1.2 |
10 % in DMSO |
|
|
|
|
Yellow LF 6911 |
9293 |
9264.5 |
2316.1 |
2.6 |
5 % in DMSO |
|
|
|
|
Yellow LF 6911 |
5662 |
5633.5 |
1408.4 |
1.6 |
2.5 % in DMSO |
|
|
|
|
HCA =a-Hexylcinnamaldehyde
AOO = Acetone: Olive oil 4:1 (v/v) mixture
DMSO = Dimethyl sulfoxide
*Group DPM = measured DPMgroup- average DPMbackground
Average DPMbackground= 28.5
# Number of animals/group = 4
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of the present assay, Yellow LF 6911 tested at the maximum feasible concentration of 25 % (w/v, based on solubility) and also at concentrations of 10 %, 5 % or 2.5 % (w/v) as formulations (apparently solutions) in a suitable vehicle (DMSO) was shown to have no skin sensitization potential in the Local Lymph Node Assay.
- Executive summary:
Since no failed treatment, sign of systemic toxicity or irritation was observed during the test no treatment group was excluded from the evaluation. Visually larger lymph nodes compared to the vehicle control (AOO) were observed in the positive control group only. Appearance of the lymph nodes was normal in the negative control groups (AOO or DMSO) and in the test item treated groups. No significant lymphoproliferative response (SI >=3) compared to the relevant control (DMSO) was noted for Yellow LF 6911at the applied test concentrations. The observed stimulation index values were 1.2, 1.2, 2.6 and 1.6 at test item concentrations of 25 %, 10 %, 5 % and 2.5 % (w/v), respectively.
Significance of the dose-response was evaluated by linear regression using the SI values. No statistical significance was observed (p = 0.44, r = 0.56).
No mortality or symptoms of systemic toxicity were observed in any treatment group. No sign of irritation (indicated by an erythema score³ 3) or any other local effect were observed in any treatment group.
No significant, treatment related effect on body weights was observed during the test. Body weight, decreased by > 5 % was observed in the AOO treatment group only (1/4 animals, 7 % decrease) but it was considered neither significant nor treatment related.
According to evaluation criteria of the relevant guidelines, the lack of a significantly increased lymphoproliferation(indicated by an SI>= 3)up to the maximum attainable concentration of 25 % (w/v, based on solubility) and also the lack of a significant
dose-response relationship are considered evidence that Yellow LF 6911is not a skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies